1863 — China Longevity Co Income Statement
0.000.00%
Basic MaterialsMicro Cap
Annual income statement for China Longevity Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 812 | 1,441 | 927 | 934 | 1,165 |
| Cost of Revenue | |||||
| Gross Profit | 189 | 260 | 146 | 186 | 203 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 754 | 1,306 | 863 | 858 | 1,091 |
| Operating Profit | 58 | 135 | 63.8 | 75.9 | 74.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 44.3 | 118 | 48.9 | 64.7 | 59 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 45 | 106 | 44.5 | 58.6 | 52 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 45 | 107 | 46.2 | 63 | 55.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 45 | 107 | 46.2 | 63 | 55.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.094 | 0.123 | 0.05 | 0.076 | 0.068 |